|
1
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the
classification of the acute leukaemias. French-American-British
(FAB) co-operative group. Br J Haematol. 33:451–458. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society, . Global Cancer
Facts & Figures. 3rd. American Cancer Society; 2015
|
|
3
|
Bain BJ: Acute leukemia cytology,
cytochemistry and the FAB classificationLeukemia Diagnosis.
Blackwell Science; Oxford, UK: pp. 1–52. 1999
|
|
4
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the human
development index (2008–2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Cancer Society, . Cancer Facts
& Figures 201s. 2014. American Cancer Society. 2014.
|
|
6
|
Morton LM, Wang SS, Devesa SS, Hartge P,
Weisenburger DD and Linet MS: Lymphoma incidence patterns by WHO
subtype in the United States, 1992–2001. Blood. 107:265–276. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watson L, Wyld P and Catovsky D: Disease
burden of chronic lymphocytic leukaemia within the European Union.
Eur J Haematol. 81:253–258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Azuma K, Ifuku S, Osaki T, Okamoto Y and
Minami S: Preparation and biomedical applications of chitin and
chitosan nanofibers. J Biomed Nanotechnol. 10:2891–2920. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Azuma K, Osaki T, Minami S and Okamoto Y:
Anticancer and anti-inflammatory properties of chitin and chitosan
oligosaccharides. J Funct Biomater. 6:33–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Domard A: A perspective on 30 years
research on chitin and chitosan. Carbohydr Polym. 84:696–703. 2011.
View Article : Google Scholar
|
|
11
|
Aam BB, Heggset EB, Norberg AL, Sørlie M,
Vårum KM and Eijsink VG: Production of chitooligosaccharides and
their potential applications in medicine. Mar Drugs. 8:1482–1517.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee E, Kim H, Lee IH and Jon S: In vivo
antitumor effects of chitosan-conjugated docetaxel after oral
administration. J Control Release. 140:79–85. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yuan WP, Liu B, Liu CH, Wang XJ, Zhang MS,
Meng XM and Xia XK: Antioxidant activity of chito-oligosaccharides
on pancreatic islet cells in streptozotocin-induced diabetes in
rats. World J Gastroenterol. 15:1339–1345. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
No HK, Park NY, Lee SH and Meyers SP:
Antibacterial activity of chitosans and chitosan oligomers with
different molecular weights. Int J Food Microbiol. 74:65–72. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Francesko A and Tzanov T: Chitin, chitosan
and derivatives for wound healing and tissue engineering. Adv
Biochem Eng Biotechnol. 125:1–27. 2011.PubMed/NCBI
|
|
16
|
Yeh MY, Wu MF, Shang HS, Chang JB, Shih
YL, Chen YL, Hung HF, Lu HF, Yeh C, Wood WG, et al: Effects of
chitosan on xenograft models of melanoma in C57BL/6 mice and
hepatoma formation in SCID mice. Anticancer Res. 33:4867–4873.
2013.PubMed/NCBI
|
|
17
|
Kim MS, Sung MJ, Seo SB, Yoo SJ, Lim WK
and Kim HM: Water-soluble chitosan inhibits the production of
pro-inflammatory cytokine in human astrocytoma cells activated by
amyloid beta peptide and interleukin-1beta. Neurosci Lett.
321:105–109. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jeong EJ, Choi M, Lee J, Rhim T and Lee
KY: The spacer arm length in cell-penetrating peptides influences
chitosan/siRNA nanoparticle delivery for pulmonary inflammation
treatment. Nanoscale. 7:20095–20104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boyles MS, Kristl T, Andosch A, Zimmermann
M, Tran N, Casals E, Himly M, Puntes V, Huber CG, Lütz-Meindl U and
Duschl A: Chitosan functionalisation of gold nanoparticles
encourages particle uptake and induces cytotoxicity and
pro-inflammatory conditions in phagocytic cells, as well as
enhancing particle interactions with serum components. J
Nanobiotechnology. 13:842015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeh MY, Shih YL, Chung HY, Chou J, Lu HF,
Liu CH, Liu JY, Huang WW, Peng SF, Wu LY and Chung JG: Chitosan
promotes immune responses, ameliorates glutamic oxaloacetic
transaminase and glutamic pyruvic transaminase, but enhances
lactate dehydrogenase levels in normal mice in vivo. Exp Ther Med.
11:1300–1306. 2016.PubMed/NCBI
|
|
21
|
Hung FM, Shang HS, Tang NY, Lin JJ, Lu KW,
Lin JP, Ko YC, Yu CC, Wang HL, Liao JC, et al: Effects of diallyl
trisulfide on induction of apoptotic death in murine leukemia
WEHI-3 cells in vitro and alterations of the immune responses in
normal and leukemic mice in vivo. Environ Toxicol. 30:1343–1353.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang YC, Lai TY, Yu CS, Chen HY, Yang JS,
Chueh FS, Lu CC, Chiang JH, Huang WW, Ma CY and Chung JG: Emodin
induces apoptotic death in murine myelomonocytic leukemia WEHI-3
cells in vitro and enhances phagocytosis in leukemia mice in vivo.
Evid Based Complement Alternat Med. 2011:5235962011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang S, Zhu J and Liu Y: A novel
anti-adhesion peptide (β3) inhibits hepatocellular carcinoma
activity in vitro and in vivo. Oncol Lett. 12:4744–4748.
2016.PubMed/NCBI
|
|
24
|
Recommendations of the german society for
clinical chemistry. Standardization of methods for the
determination of enzyme activities in biological fluids. Z Klin
Chem Klin Biochem. 8:658–660. 1970.PubMed/NCBI
|
|
25
|
Nagamatsu Y, Yamamoto J, Fukuda A, Ohta M,
Tsuda Y and Okada Y: Determination of leukocyte elastase
concentration in plasma and serum by a simple method using a
specific synthetic substrate. Haemostasis. 21:338–345.
1991.PubMed/NCBI
|
|
26
|
Wei P, Ma P, Xu QS, Bai QH, Gu JG, Xi H,
Du YG and Yu C: Chitosan oligosaccharides suppress production of
nitric oxide in lipopolysaccharide-induced N9 murine microglial
cells in vitro. Glycoconj J. 29:285–295. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Madhuprakash J, El Gueddari NE,
Moerschbacher BM and Podile AR: Production of bioactive chitosan
oligosaccharides using the hypertransglycosylating chitinase-D from
Serratia proteamaculans. Bioresour Technol. 198:503–509. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu B, Liu WS, Han BQ and Sun YY:
Antidiabetic effects of chitooligosaccharides on pancreatic islet
cells in streptozotocin-induced diabetic rats. World J
Gastroenterol. 13:725–731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu CC, Lin SY, Chen CT, Chang YP, Huang
YS, Lii CK, Yu CC, Hsieh SL and Chung JG: Differential blood
lipid-lowering effects of alkylsulfonated chitosan of different
molecular weights in Syrian hamsters in vivo. Mol Med Rep.
5:688–694. 2012.PubMed/NCBI
|
|
30
|
Arpinati M and Curti A: Immunotherapy in
acute myeloid leukemia. Immunotherapy. 6:95–106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim KH, Kim TS, Lee JG, Park JK, Yang M,
Kim JM, Jo EK and Yuk JM: Characterization of proinflammatory
responses and innate signaling activation in macrophages infected
with mycobacterium scrofulaceum. Immune Netw. 14:307–320. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gordon S, Plüddemann A and Mukhopadhyay S:
Sinusoidal immunity: Macrophages at the lymphohematopoietic
interface. Cold Spring Harb Perspect Biol. 7:a0163782015.
View Article : Google Scholar :
|
|
33
|
Gordon S and Taylor PR: Monocyte and
macrophage heterogeneity. Nat Rev Immunol. 5:953–964. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Davies LC, Jenkins SJ, Allen JE and Taylor
PR: Tissue-resident macrophages. Nat Immunol. 14:986–995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chou TC, Fu E and Shen EC: Chitosan
inhibits prostaglandin E2 formation and cyclooxygenase-2 induction
in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem
Biophys Res Commun. 308:403–407. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yoon HJ, Moon ME, Park HS, Im SY and Kim
YH: Chitosan oligosaccharide (COS) inhibits LPS-induced
inflammatory effects in RAW 264.7 macrophage cells. Biochem Biophys
Res Commun. 358:954–959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Arancibia R, Maturana C, Silva D, Tobar N,
Tapia C, Salazar JC, Martinez J and Smith PC: Effects of chitosan
particles in periodontal pathogens and gingival fibroblasts. J Dent
Res. 92:740–745. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Santoni A, Zingoni A, Cerboni C and
Gismondi A: Natural killer (NK) cells from killers to regulators:
Distinct features between peripheral blood and decidual NK cells.
Am J Reprod Immunol. 58:280–288. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yamashita T, Ohshima H, Asanuma T, Inukai
N, Miyoshi I, Kasai N, Kon Y, Watanabe T, Sato F and Kuwabara M:
The effects of alpha-phenyl-tert-butyl nitrone (PBN) on
copper-induced rat fulminant hepatitis with jaundice. Free Radic
Biol Med. 21:755–761. 1996. View Article : Google Scholar : PubMed/NCBI
|
